The Marshall Protocol Study Site Home




Search by username
   Not logged in - Login | Register 
The Marshall Protocol Study Site > PROF. MARSHALL'S PERSPECTIVE > Prof. Marshall's Perspective > Witholding ARBs after surgery increases risk of death

Witholding ARBs after surgery increases risk of death
 Moderated by: Prof Trevor Marshall
Topic closed

New Topic

Prof Trevor Marshall
Foundation Staff

Joined: Fri Jul 9th, 2004
Location: Thousand Oaks, California USA
Posts: 16539
Status:  Offline
 Posted: Thu Jun 4th, 2015 20:23

Science Daily:


"Out of 1,167,482 surgical admissions, 30,173 inpatient surgical admissions met inclusion criteria. Approximately 10,205 patients (33.8%) in the cohort did not resume ARB by day 2. Those that resumed ARB had a 30-day mortality rate of 1.3% (260 of 19,968), whereas 3.2% (323 of 10,205) died in the group that withheld ARB. The unadjusted hazard ratio (HR) for 30-day mortality was 2.45 for those that withheld ARB compared with those that resumed"

A new paper has also come out confirming that Olmesartan actually reduced plaque deposits in the 'MORE' study:


inactive member

Joined: Sun Sep 24th, 2006
Location: Newtownards, N. Ireland, United Kingdom
Posts: 1658
Status:  Offline
 Posted: Sun Jun 14th, 2015 14:38

This is one of those times I wish this platform had a like button.

Dec 2006, Olmesartan break Feb - April 2007, ME/Fibro/PTSD/MCS/Hypermobility (since childhood; disabled 2003); 25D summer 2012 <4 (meaning unable to detect)

 Current time is 05:21

* We can help you understand chronic disease, but only your physician is licensed to give you medical care *

Powered by WowBB 1.7 - Entire site Copyright © 2004-2022 Autoimmunity Research Foundation, All Rights Reserved
Click here to view our PRIVACY POLICY
Page processed in 0.0403 seconds (92% database + 8% PHP). 17 queries executed.